Blood Collection Tube for Liquid Biopsy Market Size, Share, Growth and Forecast (2026 - 2036)

Blood Collection Tube for Liquid Biopsy Market is segmented by Product (Cell Free DNA Blood Collection Tubes, Circulating Tumor Cell Collection Tubes, Standard Blood Collection Tubes, Specialized Liquid Biopsy Tubes), Application (Oncology Diagnostics, Treatment Monitoring, Minimal Residual Disease Detection, Prenatal And Genetic Testing, Research Applications), End Use (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, Pharmaceutical And Biotechnology Companies), and Region, with forecasts covering the period from 2026 to 2036.

According to Fact.MR estimates, the global blood collection tube for liquid biopsy Market was valued at USD 157.5 million in 2025. The market is projected to reach USD 188.4 million in 2026 and is expected to grow to USD 1,128.0 million by 2036, expanding at a CAGR of 19.6%. Cell Free DNA Blood Collection Tubes is anticipated to account for 44.8% of the product segment in 2026, while Oncology Diagnostics is expected to remain the leading application with around 48.6% share.

Free Sample
Download PDF

Blood Collection Tube for Liquid Biopsy Market Analysis and Forecast by Fact.MR

  • The global market for blood collection tubes designed for liquid biopsy applications is estimated at USD 188.4 million in 2026 and is forecast to expand at a CAGR of 19.6% to reach USD 1,128.0 million by 2036.
  • The market covers cell-free DNA stabilization tubes, circulating tumor cell collection tubes, standard blood collection tubes adapted for molecular analysis, and specialized multi-analyte stabilization tubes.
  • Growth is shaped by the expanding clinical adoption of liquid biopsy in oncology diagnostics, the rising number of FDA-cleared liquid biopsy assays, growing utilization in non-invasive prenatal testing, and increasing pharmaceutical investment in companion diagnostic development.

Blood Collection Tube For Liquid Biopsy Market Market Value Analysis

Summary of Blood Collection Tube for Liquid Biopsy Market

  • Market Snapshot
    • In 2025, the global Blood Collection Tube for Liquid Biopsy Market was valued at approximately USD 157.5 million.
    • The market is estimated to reach USD 188.4 million in 2026 and is projected to attain USD 1128.0 million by 2036.
    • The blood collection tube for liquid biopsy market is likely to expand at a CAGR of 19.6% during the forecast period.
    • The market is anticipated to create an absolute dollar opportunity of USD 939.6 million between 2026 and 2036.
    • Cell-free DNA blood collection tubes account for 44.8% of the product type share in 2026.
    • China (26.5%) and India (24.5%) are the key growth markets during the forecast period.
  • Demand and Growth Drivers
    • Expanding clinical adoption of liquid biopsy for cancer detection, treatment monitoring, and minimal residual disease assessment is creating growing demand for specialized blood collection tubes that preserve cell-free DNA integrity.
    • Rising number of FDA-cleared and CE-marked liquid biopsy assays requiring validated pre-analytical workflows is increasing procurement of cfDNA-stabilizing collection tubes across reference laboratories.
    • Growing utilization of non-invasive prenatal testing (NIPT) for genetic screening is expanding the addressable market for cell-free DNA collection tubes beyond oncology.
    • Increasing pharmaceutical investment in companion diagnostics and biomarker-driven clinical trials is driving demand for standardized blood collection formats that ensure sample quality across multi-site studies.
    • Expanding molecular diagnostic laboratory infrastructure in China, India, and Brazil is creating first-time procurement demand for liquid biopsy-compatible collection systems.
  • Product and Segment View
    • Cell-free DNA blood collection tubes account for 44.8% of the product type segment in 2026, supported by the dominant role of cfDNA analysis in oncology liquid biopsy workflows.
    • Oncology diagnostics account for 48.6% of the application segment in 2026, with lung cancer, breast cancer, and colorectal cancer detection acting as the primary demand channels.
    • Hospitals account for 42.3% of the end use segment in 2026, driven by growing in-house molecular diagnostic capabilities in hospital pathology laboratories.
  • Key segmentation includes:
    • Product Type: Cell-Free DNA Blood Collection Tubes, Circulating Tumor Cell Collection Tubes, Standard Blood Collection Tubes, Specialized Liquid Biopsy Tubes
    • Application: Oncology Diagnostics, Treatment Monitoring, Minimal Residual Disease Detection, Prenatal and Genetic Testing, Research Applications
    • End Use: Hospitals, Diagnostic Laboratories, Cancer Research Institutes, Pharmaceutical and Biotechnology Companies
    • Technology: Cell-Free DNA Preservation Technology, Cell Stabilization Technology, Multi-Omics Stabilization Technology
    • Sample Type: Plasma Samples, Whole Blood Samples, Serum Samples
    • Distribution Channel: Direct Sales, Distributors, Online Channels
  • These systems enable:
    • Stabilization of cell-free DNA at draw-time concentrations for reliable downstream molecular analysis.
    • Preservation of circulating tumor cells for enumeration and genomic characterization.
    • Standardized pre-analytical workflows that support multi-site clinical trials and reference laboratory testing.
  • Geography and Competitive Outlook
    • North America remains a leading regional market, supported by the highest concentration of liquid biopsy assay developers, reference laboratories, and clinical trial activity globally.
    • Europe shows steady demand shaped by expanding molecular diagnostic infrastructure and growing adoption of liquid biopsy in clinical oncology practice.
    • Asia Pacific is the fastest-growing region, with China and India leading through expanding molecular diagnostic laboratory buildout and growing adoption of cancer screening programs.
    • China (26.5%) and India (24.5%) are the key growth markets, while the USA, Germany, and UK maintain strong clinical adoption patterns.
    • Key players include Streck, Inc., Qiagen N.V., Roche Holding AG, PreAnalytiX GmbH, and Greiner Bio-One International GmbH.
  • Analyst Opinion
    • Shambhu Nath Jha, Principal Consultant at Fact.MR, says 'The blood collection tube for liquid biopsy market is at an inflection point. As liquid biopsy moves from research to clinical standard of care, the pre-analytical supply chain is becoming a critical differentiator. Companies that establish their tubes as the validated collection format within FDA-cleared assay workflows will build strong switching costs. The opportunity is not in the tube itself but in becoming the embedded pre-analytical standard across oncology diagnostics, companion diagnostics, and multi-cancer early detection programs.'

Key Growth Drivers, Constraints, and Opportunities

Blood Collection Tube For Liquid Biopsy Market Opportunity Matrix Growth Vs Value

Key Factors Driving Growth

  • Expanding clinical adoption of liquid biopsy across oncology diagnostics is creating sustained demand for cfDNA-stabilizing blood collection tubes validated within cleared assay workflows.
  • Growing number of multi-cancer early detection programs and population-level screening initiatives are increasing per-capita tube consumption in developed markets.
  • Rising pharmaceutical investment in companion diagnostics and biomarker-driven clinical trials is expanding tube procurement through contract research organizations and central laboratories.

Key Market Constraints

  • High per-tube cost of specialized cfDNA collection tubes compared to standard EDTA tubes limits adoption in price-sensitive and high-volume screening settings.
  • Limited standardization across liquid biopsy pre-analytical workflows creates fragmentation in tube selection and procurement across laboratories using different assay platforms.
  • Regulatory complexity around validated pre-analytical components adds compliance burden for tube manufacturers seeking to establish their products within cleared diagnostic workflows.

Key Opportunity Areas

  • Multi-cancer early detection programs represent a large volume growth opportunity as population-level screening expands tube consumption from specialist oncology to primary care settings.
  • Development of multi-analyte stabilization tubes that preserve cfDNA, RNA, proteins, and exosomes in a single tube format is creating premium product tiers for multi-omics liquid biopsy applications.
  • Expansion of molecular diagnostic laboratory infrastructure in China, India, and Brazil is creating first-time procurement demand for liquid biopsy-compatible collection systems at scale.

Segment-wise Analysis of the Blood Collection Tube for Liquid Biopsy Market

  • Cell-free DNA blood collection tubes hold 44.8% of the product type segment in 2026, supported by the dominant role of cfDNA analysis in clinical liquid biopsy applications and validated integration with FDA-cleared assay workflows.
  • Oncology diagnostics represents 48.6% of the application segment in 2026, with lung cancer, breast cancer, and colorectal cancer detection and monitoring acting as the primary demand channels.
  • Specialized liquid biopsy tubes including multi-analyte and RNA stabilization formats are growing faster in percentage terms, with adoption rising as multi-omics approaches expand beyond cfDNA-only analysis.

The blood collection tube for liquid biopsy market is segmented by product type, application, end use, technology, sample type, distribution channel, and region. By product type, the market covers cell-free DNA tubes, CTC collection tubes, standard adapted tubes, and specialized multi-analyte tubes. By application, coverage includes oncology diagnostics, treatment monitoring, minimal residual disease detection, prenatal testing, and research. Cell-free DNA tubes lead by value due to their validated role in clinical oncology, while multi-analyte tubes are expected to drive the next phase of growth.

Which Product Type Segment Dominates the Blood Collection Tube for Liquid Biopsy Market?

Blood Collection Tube For Liquid Biopsy Market Analysis By Product

Cell-free DNA blood collection tubes are expected to account for 44.8% of the product type segment in 2026, supported by their established role as the standard pre-analytical component for liquid biopsy workflows in clinical oncology. cfDNA tubes from Streck, Roche (PreAnalytiX), and Qiagen have been validated within multiple FDA-cleared and CE-marked assay systems, creating strong procurement linkages with reference laboratory workflows.

Circulating tumor cell collection tubes and specialized multi-analyte stabilization tubes represent growing segments, with adoption rising as liquid biopsy applications expand beyond cfDNA analysis into CTC enumeration, exosome characterization, and multi-omics profiling. Multi-analyte tubes are especially relevant for pharmaceutical biomarker studies where preservation of multiple analyte classes in a single draw is commercially valuable.

Which Application Segment Dominates the Blood Collection Tube for Liquid Biopsy Market?

Blood Collection Tube For Liquid Biopsy Market Analysis By Application

Oncology diagnostics are expected to account for 48.6% of the application segment in 2026. Demand is shaped by the expanding use of liquid biopsy for cancer detection, therapy response monitoring, and minimal residual disease assessment across lung, breast, colorectal, and prostate cancer indications. Each cleared oncology liquid biopsy assay creates a recurring tube procurement stream.

Treatment monitoring and minimal residual disease detection follow as significant applications, with longitudinal patient monitoring creating repeat collection tube demand over extended treatment periods. Prenatal and genetic testing also contributes meaningfully, with NIPT programs generating high-volume tube consumption in reproductive health laboratories.

Which End Use Segment Dominates the Blood Collection Tube for Liquid Biopsy Market?

Blood Collection Tube For Liquid Biopsy Market Analysis By End Use

Hospitals account for 42.3% of the end use segment in 2026, driven by growing in-house molecular diagnostic capabilities in hospital oncology and pathology departments. Hospital procurement is increasingly linked to assay platform selection, with tube purchasing bundled into laboratory supply contracts.

Diagnostic laboratories, including reference laboratories and molecular diagnostic labs, represent the second largest end use channel. These laboratories process the highest volumes of liquid biopsy tests and maintain validated procurement relationships with specific tube manufacturers based on assay validation requirements.

Which Product Trend is Shaping the Next Phase of Growth in the Blood Collection Tube for Liquid Biopsy Market?

Multi-analyte stabilization tubes are not yet the largest product segment, but they are emerging as the fastest-growing capability in the market. Their adoption is projected to rise as liquid biopsy applications expand from cfDNA-only analysis toward integrated multi-omics profiling that requires simultaneous preservation of DNA, RNA, proteins, and extracellular vesicles in a single blood draw.

The shift toward multi-analyte tubes reflects a broader change in how liquid biopsy is used in both clinical and pharmaceutical settings. Researchers and clinicians increasingly need comprehensive molecular profiles from a single sample, and pharmaceutical companies running biomarker-intensive clinical trials require tubes that preserve multiple analyte classes without separate collection protocols. Companies that develop validated multi-analyte stabilization chemistry with broad assay compatibility are positioned to capture this transition.

Regional Outlook Across Key Markets

Top Country Growth Comparison Blood Collection Tube For Liquid Biopsy Market Cagr (2026 2036)

  • China leads growth at 26.5%, supported by rapid molecular diagnostic laboratory expansion, growing adoption of liquid biopsy in hospital oncology departments, and government investment in cancer screening programs.
  • India follows at 24.5%, driven by growing diagnostic laboratory infrastructure, rising cancer diagnosis volumes, and expanding access to molecular testing in urban hospital networks.
  • Germany at 22.5% benefits from strong clinical adoption of liquid biopsy, established reference laboratory networks, and supportive reimbursement for molecular oncology diagnostics.
  • The U.S. at 18.6% reflects a mature market with growth driven by expanding multi-cancer early detection programs, new assay clearances, and growing companion diagnostic utilization.

CAGR Table

Country CAGR (%)
China 26.5%
India 24.5%
Germany 22.5%
Brazil 20.6%
USA 18.6%
UK 16.7%
Japan 14.7%

Source: Fact MR (FMR) analysis, based on proprietary forecasting model and primary research.

Blood Collection Tube For Liquid Biopsy Market Cagr Analysis By Country

Market Outlook for Blood Collection Tubes for Liquid Biopsy in the United States

Blood Collection Tube For Liquid Biopsy Market Country Value Analysis

The U.S. blood collection tube for liquid biopsy market is projected to grow at a CAGR of 18.6% through 2036. Demand is shaped by the highest concentration of cleared liquid biopsy assays globally, expanding multi-cancer early detection programs, and strong pharmaceutical clinical trial activity.

  • Cleared assay expansion creates validated procurement pathways for cfDNA collection tubes.
  • Multi-cancer early detection programs are scaling tube consumption toward population-level volumes.
  • Pharmaceutical companion diagnostic investment sustains research-grade tube demand.

China Blood Collection Tube for Liquid Biopsy Market Growth Assessment

The China blood collection tube for liquid biopsy market is projected to grow at a CAGR of 26.5% through 2036, making it the fastest-growing country in the study. Growth is supported by rapid molecular diagnostic laboratory buildout, government cancer screening investments, and growing domestic liquid biopsy assay development.

  • Molecular diagnostic laboratory expansion drives first-time specialized tube procurement.
  • Government cancer screening programs increase liquid biopsy utilization at scale.
  • Domestic assay developers are creating local demand for validated collection tubes.

Blood Collection Tube for Liquid Biopsy Demand Trends in India

The India blood collection tube for liquid biopsy market is projected to grow at a CAGR of 24.5% through 2036. Demand is shaped by growing diagnostic laboratory infrastructure, rising cancer diagnosis volumes, and expanding molecular testing access in urban hospital networks.

  • Diagnostic laboratory growth is creating procurement demand for specialized collection tubes.
  • Rising cancer diagnosis volumes expand liquid biopsy test utilization.
  • Urban hospital investment in molecular diagnostics supports tube adoption.

Germany Blood Collection Tube for Liquid Biopsy Market Demand Analysis

The Germany blood collection tube for liquid biopsy market is projected to grow at a CAGR of 22.5% through 2036. Demand is supported by established reference laboratory networks, clinical adoption of liquid biopsy in oncology, and supportive reimbursement for molecular diagnostics.

  • Established reference laboratories maintain structured procurement for validated tubes.
  • Clinical oncology adoption of liquid biopsy sustains diagnostic tube demand.
  • Reimbursement support for molecular testing improves liquid biopsy utilization rates.

Competitive Benchmarking and Company Positioning

Blood Collection Tube For Liquid Biopsy Market Analysis By Company

Blood Collection Tube for Liquid Biopsy Market Analysis By Company

  • Streck, Inc., Qiagen N.V., and Roche Holding AG (through PreAnalytiX) hold strong positions in the global blood collection tube for liquid biopsy market through validated cfDNA stabilization products, integration with cleared assay workflows, and established procurement relationships with reference laboratories.
  • Norgen Biotek Corp., Greiner Bio-One International GmbH, and Biocept, Inc. compete through specialized product offerings, multi-analyte stabilization chemistry, and partnerships with assay developers in oncology and prenatal testing.
  • Assay validation partnerships and regulatory integration create significant switching costs, as laboratories are unlikely to change collection tubes once a specific format is validated within their cleared diagnostic workflows.

The competitive landscape is moderately concentrated, with Streck maintaining the largest share through its Cell-Free DNA BCT platform, which has become a de facto standard in many liquid biopsy workflows. Competition is shaped by validation status within cleared assays, preservation performance, sample stability duration, and pricing in volume procurement.

Strategic priorities include expanding validation partnerships with assay developers, developing multi-analyte stabilization formats, extending sample stability windows, and building direct procurement relationships with reference laboratories and pharmaceutical central laboratories.

Key Companies in the Blood Collection Tube for Liquid Biopsy Market

  • Streck, Inc., Qiagen N.V., and Roche Holding AG (through PreAnalytiX) are among the leading players globally, with Streck maintaining the largest share through its established Cell-Free DNA BCT platform.
  • Norgen Biotek Corp., Greiner Bio-One International GmbH, and Biocept, Inc. hold positions in specialized segments including multi-analyte stabilization and CTC collection.
  • Geneseeq Technology Inc., Apostle Inc., Exact Sciences Corp, and other companies compete through focused product offerings and regional distribution strength.

Recent Industry Developments

  • Streck, Inc. / Product Platform Expansion / cfDNA BCT Validation (2025)
    • Streck continued to expand validation partnerships for its Cell-Free DNA BCT platform, supporting integration with newly cleared liquid biopsy assays for oncology diagnostics and multi-cancer early detection applications.
  • Roche Holding AG / Liquid Biopsy Ecosystem Expansion (2025)
    • Roche expanded its liquid biopsy ecosystem through continued development of its cell-free DNA collection tube portfolio in partnership with Qiagen through the PreAnalytiX joint venture, supporting standardized pre-analytical workflows for companion diagnostic programs.
  • Exact Sciences Corp / Multi-Cancer Early Detection Program Expansion (2025)
    • Exact Sciences expanded its multi-cancer early detection testing program, generating growing procurement demand for validated cfDNA blood collection tubes across clinical sites and reference laboratories.

Leading Companies Shaping the Blood Collection Tube for Liquid Biopsy Market

  • Streck, Inc.
  • Qiagen N.V.
  • Roche Holding AG
  • Biocept, Inc.
  • PreAnalytiX GmbH (BD and Qiagen JV)
  • Norgen Biotek Corp.
  • Greiner Bio-One International GmbH
  • Geneseeq Technology Inc.
  • Apostle Inc.
  • Exact Sciences Corp

Sources and Research References

  • Streck, Inc. Cell-Free DNA BCT product portfolio and validation data.
  • Qiagen N.V. PAXgene Blood ccfDNA Tube product updates.
  • Roche Holding AG. Liquid biopsy collection tube portfolio through PreAnalytiX.
  • U.S. Food and Drug Administration (FDA). Liquid biopsy assay clearance records.
  • National Cancer Institute (NCI). Cancer screening and liquid biopsy clinical trial data.
  • Primary interviews with tube manufacturers, reference laboratory directors, assay developers, clinical pathologists, and pharmaceutical biomarker teams.
  • This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

Key Questions This Report Addresses

  • What is the current and future size of the blood collection tube for liquid biopsy market?
  • How fast is the market expected to grow between 2026 and 2036?
  • Which product type is likely to lead the market by 2026?
  • Which application segment is expected to account for the highest demand by 2026?
  • What factors are driving demand for liquid biopsy blood collection tubes globally?
  • How is multi-cancer early detection expanding the addressable market?
  • Why are China and India the fastest-growing markets?
  • How do assay validation partnerships influence tube procurement?
  • Which countries are projected to show the fastest growth through 2036?
  • Who are the key companies active in the market?
  • What role does pre-analytical standardization play in market growth?
  • How does Fact.MR estimate and validate the market forecast?

Blood Collection Tube for Liquid Biopsy Market Definition

The blood collection tube for liquid biopsy market covers specialized blood collection devices designed to stabilize cell-free DNA, circulating tumor cells, RNA, exosomes, and other analytes in whole blood samples for downstream molecular analysis in oncology diagnostics, prenatal testing, and biomarker research.

Blood Collection Tube for Liquid Biopsy Market Inclusions

  • The scope covers global and regional market size and forecasts for 2026 to 2036 across product type, application, end use, technology, sample type, distribution channel, and region.
  • It includes regional demand analysis based on liquid biopsy assay adoption, molecular diagnostic laboratory density, clinical trial activity, and cancer screening program expansion.
  • The report includes pricing and cost analysis across cfDNA tubes, CTC collection tubes, and specialized stabilization tubes, including per-tube costs and volume procurement economics.
  • It covers technology trends, market drivers and constraints, and the competitive landscape, including product portfolios, assay validation partnerships, and distribution strategies of leading players.

Blood Collection Tube for Liquid Biopsy Market Exclusions

  • The scope excludes general-purpose blood collection tubes (EDTA, serum, heparin) used for routine hematology and chemistry testing without liquid biopsy-specific stabilization chemistry.
  • It excludes liquid biopsy assay kits, sequencing platforms, and molecular diagnostic instruments sold without blood collection tube components.
  • The report excludes tissue biopsy consumables, sample transport containers, and laboratory processing equipment.
  • It also excludes point-of-care blood collection devices and capillary blood sampling systems not validated for liquid biopsy workflows.

Blood Collection Tube for Liquid Biopsy Market Research Methodology

  • The methodology combines secondary research, primary interviews, and forecast modelling.
  • It draws on 100+ secondary sources and benchmarks 40+ company product portfolios.
  • Market sizing covers 30+ countries through a demand-side model supported by top-down validation.
  • Key inputs include liquid biopsy assay adoption rates, molecular diagnostic laboratory counts, clinical trial volumes, and cancer screening program budgets.
  • The model cross-checks demand with tube shipment data, pricing trends, and assay validation partnerships.
  • Primary validation includes 20+ interviews across tube manufacturers, laboratory procurement teams, assay developers, and clinical pathologists.
  • Final estimates go through assay-volume checks, procurement-pattern review, and sensitivity testing.

Scope of Analysis

Blood Collection Tube For Liquid Biopsy Market Breakdown By Product, Application, And Region

Parameter Details
Quantitative Units USD 188.4 million to USD 1128.0 million, at a CAGR of 19.6%
Market Definition The blood collection tube for liquid biopsy market covers specialized blood collection devices designed to stabilize cell-free DNA, circulating tumor cells, RNA, exosomes, and other analytes in whole blood for downstream molecular analysis in oncology, prenatal testing, and biomarker research.
Regions Covered North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered China, India, Germany, Brazil, USA, UK, Japan, 30 plus countries
Key Companies Streck, Inc., Qiagen N.V., Roche Holding AG, Biocept, Inc., PreAnalytiX GmbH (BD and Qiagen JV), Norgen Biotek Corp., Greiner Bio-One International GmbH, Geneseeq Technology Inc., Apostle Inc., Exact Sciences Corp
Forecast Period 2026 to 2036
Approach Hybrid demand-side and top-down methodology built on liquid biopsy assay adoption rates, molecular laboratory counts, clinical trial activity, tube shipment validation, and primary interviews across tube manufacturers, laboratory directors, assay developers, and clinical pathologists

Blood Collection Tube for Liquid Biopsy Market Segmentation

  • Blood Collection Tube for Liquid Biopsy Market Segmented by Product:

    • Cell Free DNA Blood Collection Tubes
      • Plasma Stabilization Tubes
        • DNA Stabilizing Tubes
        • Preservative Based Tubes
      • Cell Preservation Tubes
        • Intact Cell Stabilization Tubes
    • Circulating Tumor Cell Collection Tubes
      • CTC Enrichment Tubes
      • CTC Preservation Tubes
    • Standard Blood Collection Tubes
      • EDTA Tubes
        • K2 EDTA Tubes
        • K3 EDTA Tubes
      • Serum Separation Tubes
      • Plasma Separation Tubes
    • Specialized Liquid Biopsy Tubes
      • Multi Analyte Stabilization Tubes
      • RNA Stabilization Tubes
      • Exosome Collection Tubes

  • Blood Collection Tube for Liquid Biopsy Market Segmented by Application:

    • Oncology Diagnostics
      • Lung Cancer Detection
      • Breast Cancer Detection
      • Colorectal Cancer Detection
      • Prostate Cancer Detection
    • Treatment Monitoring
      • Therapy Response Monitoring
      • Drug Resistance Monitoring
    • Minimal Residual Disease Detection
      • Post Treatment Surveillance
      • Recurrence Monitoring
    • Prenatal And Genetic Testing
      • Non Invasive Prenatal Testing
      • Genetic Disorder Screening
    • Research Applications
      • Biomarker Discovery
      • Clinical Trials

  • Blood Collection Tube for Liquid Biopsy Market Segmented by End Use:

    • Hospitals
      • Oncology Departments
      • Clinical Pathology Laboratories
    • Diagnostic Laboratories
      • Reference Laboratories
      • Molecular Diagnostic Labs
    • Cancer Research Institutes
      • Academic Medical Centers
      • Translational Research Labs
    • Pharmaceutical And Biotechnology Companies
      • Drug Development Laboratories
      • Biomarker Development Units

  • Blood Collection Tube for Liquid Biopsy Market Segmented by Technology:

    • Cell Free DNA Preservation Technology
      • Nucleic Acid Stabilization Chemistry
      • Plasma Separation Stabilization
    • Cell Stabilization Technology
      • Circulating Tumor Cell Preservation
      • Blood Cell Integrity Maintenance
    • Multi Omics Stabilization Technology
      • DNA RNA Protein Stabilization
      • Exosome Preservation Systems

  • Blood Collection Tube for Liquid Biopsy Market Segmented by Sample Type:

    • Plasma Samples
      • Cell Free Plasma
      • Stabilized Plasma Samples
    • Whole Blood Samples
      • Stabilized Whole Blood
      • Cell Preserved Blood
    • Serum Samples
      • Separated Serum
      • Processed Serum Samples

  • Blood Collection Tube for Liquid Biopsy Market Segmented by Distribution Channel:

    • Direct Sales
      • Hospital Procurement
      • Laboratory Procurement
    • Distributors
      • Medical Device Distributors
      • Regional Suppliers
    • Online Channels
      • B2B Platforms
      • Ecommerce Portals

  • Blood Collection Tube for Liquid Biopsy Market by Region:

    • North America
      • USA
      • Canada
      • Mexico
    • Latin America
      • Brazil
      • Chile
      • Rest of Latin America
    • Western Europe
      • Germany
      • UK
      • Italy
      • Spain
      • France
      • Nordic
      • BENELUX
      • Rest of Western Europe
    • Eastern Europe
      • Russia
      • Poland
      • Hungary
      • Balkan & Baltic
      • Rest of Eastern Europe
    • East Asia
      • China
      • Japan
      • South Korea
    • South Asia and Pacific
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of South Asia and Pacific
    • Middle East & Africa
      • Kingdom of Saudi Arabia
      • Other GCC Countries
      • Turkiye
      • South Africa
      • Other African Union
      • Rest of Middle East & Africa

- Frequently Asked Questions -

How big is the blood collection tube for liquid biopsy market in 2025?

The global blood collection tube for liquid biopsy market is estimated to be valued at USD 157.5 million in 2025.

What will be the size of the blood collection tube for liquid biopsy market in 2036?

The market size for the blood collection tube for liquid biopsy market is projected to reach USD 1,128.0 million by 2036.

How much will the blood collection tube for liquid biopsy market grow between 2026 and 2036?

The blood collection tube for liquid biopsy market is expected to grow at a 19.6% CAGR between 2026 and 2036.

What are the key product types in the blood collection tube for liquid biopsy market?

The key product types in the blood collection tube for liquid biopsy market include cell-free DNA blood collection tubes, circulating tumor cell collection tubes, standard blood collection tubes, and specialized liquid biopsy tubes.

Which application segment will contribute significant share in the blood collection tube for liquid biopsy market in 2026?

In terms of application, oncology diagnostics are expected to account for 48.6% share in the blood collection tube for liquid biopsy market in 2026.

Which are the fastest-growing countries in the blood collection tube for liquid biopsy market?

China (26.5%) and India (24.5%) are the fastest-growing countries in the blood collection tube for liquid biopsy market during the forecast period.

Table of Content

  1. Executive Summary
    • Global Market Outlook
    • Demand to side Trends
    • Supply to side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Research Methodology
    • Chapter Orientation
    • Analytical Lens and Working Hypotheses
      • Market Structure, Signals, and Trend Drivers
      • Benchmarking and Cross-market Comparability
      • Market Sizing, Forecasting, and Opportunity Mapping
    • Research Design and Evidence Framework
      • Desk Research Programme (Secondary Evidence)
        • Company Annual and Sustainability Reports
        • Peer-reviewed Journals and Academic Literature
        • Corporate Websites, Product Literature, and Technical Notes
        • Earnings Decks and Investor Briefings
        • Statutory Filings and Regulatory Disclosures
        • Technical White Papers and Standards Notes
        • Trade Journals, Industry Magazines, and Analyst Briefs
        • Conference Proceedings, Webinars, and Seminar Materials
        • Government Statistics Portals and Public Data Releases
        • Press Releases and Reputable Media Coverage
        • Specialist Newsletters and Curated Briefings
        • Sector Databases and Reference Repositories
        • Fact.MR Internal Proprietary Databases and Historical Market Datasets
        • Subscription Datasets and Paid Sources
        • Social Channels, Communities, and Digital Listening Inputs
        • Additional Desk Sources
      • Expert Input and Fieldwork (Primary Evidence)
        • Primary Modes
          • Qualitative Interviews and Expert Elicitation
          • Quantitative Surveys and Structured Data Capture
          • Blended Approach
        • Why Primary Evidence is Used
        • Field Techniques
          • Interviews
          • Surveys
          • Focus Groups
          • Observational and In-context Research
          • Social and Community Interactions
        • Stakeholder Universe Engaged
          • C-suite Leaders
          • Board Members
          • Presidents and Vice Presidents
          • R&D and Innovation Heads
          • Technical Specialists
          • Domain Subject-matter Experts
          • Scientists
          • Physicians and Other Healthcare Professionals
        • Governance, Ethics, and Data Stewardship
          • Research Ethics
          • Data Integrity and Handling
      • Tooling, Models, and Reference Databases
    • Data Engineering and Model Build
      • Data Acquisition and Ingestion
      • Cleaning, Normalisation, and Verification
      • Synthesis, Triangulation, and Analysis
    • Quality Assurance and Audit Trail
  4. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  5. Global Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
    • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
      • Y to o to Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  6. Global Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
  7. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Product
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Product, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Product, 2026 to 2036
      • Cell Free DNA Blood Collection Tubes
        • Plasma Stabilization Tubes
        • _DNA Stabilizing Tubes
        • _Preservative Based Tubes
        • Cell Preservation Tubes
        • _Intact Cell Stabilization Tubes
      • Circulating Tumor Cell Collection Tubes
        • CTC Enrichment Tubes
        • CTC Preservation Tubes
      • Standard Blood Collection Tubes
        • EDTA Tubes
        • _K2 EDTA Tubes
        • _K3 EDTA Tubes
        • Serum Separation Tubes
        • Plasma Separation Tubes
      • Specialized Liquid Biopsy Tubes
        • Multi Analyte Stabilization Tubes
        • RNA Stabilization Tubes
        • Exosome Collection Tubes
    • Y to o to Y Growth Trend Analysis By Product, 2021 to 2025
    • Absolute $ Opportunity Analysis By Product, 2026 to 2036
  8. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Application
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Application, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2026 to 2036
      • Oncology Diagnostics
        • Lung Cancer Detection
        • Breast Cancer Detection
        • Colorectal Cancer Detection
        • Prostate Cancer Detection
      • Treatment Monitoring
        • Therapy Response Monitoring
        • Drug Resistance Monitoring
      • Minimal Residual Disease Detection
        • Post Treatment Surveillance
        • Recurrence Monitoring
      • Prenatal And Genetic Testing
        • Non Invasive Prenatal Testing
        • Genetic Disorder Screening
      • Research Applications
        • Biomarker Discovery
        • Clinical Trials
    • Y to o to Y Growth Trend Analysis By Application, 2021 to 2025
    • Absolute $ Opportunity Analysis By Application, 2026 to 2036
  9. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By End Use
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By End Use, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By End Use, 2026 to 2036
      • Hospitals
        • Oncology Departments
        • Clinical Pathology Laboratories
      • Diagnostic Laboratories
        • Reference Laboratories
        • Molecular Diagnostic Labs
      • Cancer Research Institutes
        • Academic Medical Centers
        • Translational Research Labs
      • Pharmaceutical And Biotechnology Companies
        • Drug Development Laboratories
        • Biomarker Development Value (USD Million)s
    • Y to o to Y Growth Trend Analysis By End Use, 2021 to 2025
    • Absolute $ Opportunity Analysis By End Use, 2026 to 2036
  10. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Technology
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Technology, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Technology, 2026 to 2036
      • Cell Free DNA Preservation Technology
        • Nucleic Acid Stabilization Chemistry
        • Plasma Separation Stabilization
      • Cell Stabilization Technology
        • Circulating Tumor Cell Preservation
        • Blood Cell Integrity Maintenance
      • Multi Omics Stabilization Technology
        • DNA RNA Protein Stabilization
        • Exosome Preservation Systems
    • Y to o to Y Growth Trend Analysis By Technology, 2021 to 2025
    • Absolute $ Opportunity Analysis By Technology, 2026 to 2036
  11. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Sample Type
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Sample Type, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Sample Type, 2026 to 2036
      • Plasma Samples
        • Cell Free Plasma
        • Stabilized Plasma Samples
      • Whole Blood Samples
        • Stabilized Whole Blood
        • Cell Preserved Blood
      • Serum Samples
        • Separated Serum
        • Processed Serum Samples
    • Y to o to Y Growth Trend Analysis By Sample Type, 2021 to 2025
    • Absolute $ Opportunity Analysis By Sample Type, 2026 to 2036
  12. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Distribution Channel
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Distribution Channel, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Distribution Channel, 2026 to 2036
      • Direct Sales
        • Hospital Procurement
        • Laboratory Procurement
      • Distributors
        • Medical Device Distributors
        • Regional Suppliers
      • Online Channels
        • B2B Platforms
        • Ecommerce Portals
    • Y to o to Y Growth Trend Analysis By Distribution Channel, 2021 to 2025
    • Absolute $ Opportunity Analysis By Distribution Channel, 2026 to 2036
  13. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
      • North America
      • Latin America
      • Western Europe
      • Eastern Europe
      • East Asia
      • South Asia and Pacific
      • Middle East & Africa
    • Market Attractiveness Analysis By Region
  14. North America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • USA
        • Canada
        • Mexico
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Key Takeaways
  15. Latin America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Brazil
        • Chile
        • Rest of Latin America
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Key Takeaways
  16. Western Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Germany
        • UK
        • Italy
        • Spain
        • France
        • Nordic
        • BENELUX
        • Rest of Western Europe
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Key Takeaways
  17. Eastern Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Russia
        • Poland
        • Hungary
        • Balkan & Baltic
        • Rest of Eastern Europe
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Key Takeaways
  18. East Asia Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • China
        • Japan
        • South Korea
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Key Takeaways
  19. South Asia and Pacific Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of South Asia and Pacific
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Key Takeaways
  20. Middle East & Africa Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Kingdom of Saudi Arabia
        • Other GCC Countries
        • Turkiye
        • South Africa
        • Other African Union
        • Rest of Middle East & Africa
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
    • Key Takeaways
  21. Key Countries Market Analysis
    • USA
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Canada
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Mexico
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Brazil
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Chile
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • UK
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Italy
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Spain
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • France
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • India
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • ASEAN
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Australia & New Zealand
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • China
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Japan
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • South Korea
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Russia
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Poland
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Hungary
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Kingdom of Saudi Arabia
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • Turkiye
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
    • South Africa
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Application
        • By End Use
        • By Technology
        • By Sample Type
        • By Distribution Channel
  22. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Product
      • By Application
      • By End Use
      • By Technology
      • By Sample Type
      • By Distribution Channel
  23. Competition Analysis
    • Competition Deep Dive
      • Streck, Inc.
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • Qiagen N.V.
      • Roche Holding AG
      • Biocept, Inc.
      • PreAnalytiX GmbH (BD & Qiagen JV)
      • Norgen Biotek Corp.
      • Greiner Bio-One International GmbH
      • Geneseeq Technology Inc.
      • Apostle Inc.
      • Exact Sciences Corp
  24. Assumptions & Acronyms Used

List Of Table

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
  • Table 2: Global Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 3: Global Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 4: Global Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 5: Global Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 6: Global Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 7: Global Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
  • Table 8: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 9: North America Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 10: North America Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 11: North America Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 12: North America Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 13: North America Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 14: North America Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
  • Table 15: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 16: Latin America Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 17: Latin America Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 18: Latin America Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 19: Latin America Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 20: Latin America Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 21: Latin America Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
  • Table 22: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 23: Western Europe Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 24: Western Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 25: Western Europe Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 26: Western Europe Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 27: Western Europe Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 28: Western Europe Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
  • Table 29: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 30: Eastern Europe Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 31: Eastern Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 32: Eastern Europe Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 33: Eastern Europe Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 34: Eastern Europe Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 35: Eastern Europe Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
  • Table 36: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 37: East Asia Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 38: East Asia Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 39: East Asia Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 40: East Asia Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 41: East Asia Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 42: East Asia Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
  • Table 43: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 44: South Asia and Pacific Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 45: South Asia and Pacific Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 46: South Asia and Pacific Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 47: South Asia and Pacific Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 48: South Asia and Pacific Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 49: South Asia and Pacific Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
  • Table 50: Middle East & Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 51: Middle East & Africa Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 52: Middle East & Africa Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 53: Middle East & Africa Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 54: Middle East & Africa Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 55: Middle East & Africa Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 56: Middle East & Africa Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036

List Of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2021 to 2036
  • Figure 3: Global Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 4: Global Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 5: Global Market Attractiveness Analysis by Product
  • Figure 6: Global Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 7: Global Market Y-o-Y Growth Comparison by Application, 2026 to 2036
  • Figure 8: Global Market Attractiveness Analysis by Application
  • Figure 9: Global Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 10: Global Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 11: Global Market Attractiveness Analysis by End Use
  • Figure 12: Global Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 13: Global Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 14: Global Market Attractiveness Analysis by Technology
  • Figure 15: Global Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 16: Global Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 17: Global Market Attractiveness Analysis by Sample Type
  • Figure 18: Global Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
  • Figure 19: Global Market Y-o-Y Growth Comparison by Distribution Channel, 2026 to 2036
  • Figure 20: Global Market Attractiveness Analysis by Distribution Channel
  • Figure 21: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
  • Figure 22: Global Market Y-o-Y Growth Comparison by Region, 2026 to 2036
  • Figure 23: Global Market Attractiveness Analysis by Region
  • Figure 24: North America Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 25: Latin America Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 26: Western Europe Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 27: Eastern Europe Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 28: East Asia Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 29: South Asia and Pacific Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 30: Middle East & Africa Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 31: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 32: North America Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 33: North America Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 34: North America Market Attractiveness Analysis by Product
  • Figure 35: North America Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 36: North America Market Y-o-Y Growth Comparison by Application, 2026 to 2036
  • Figure 37: North America Market Attractiveness Analysis by Application
  • Figure 38: North America Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 39: North America Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 40: North America Market Attractiveness Analysis by End Use
  • Figure 41: North America Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 42: North America Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 43: North America Market Attractiveness Analysis by Technology
  • Figure 44: North America Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 45: North America Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 46: North America Market Attractiveness Analysis by Sample Type
  • Figure 47: North America Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
  • Figure 48: North America Market Y-o-Y Growth Comparison by Distribution Channel, 2026 to 2036
  • Figure 49: North America Market Attractiveness Analysis by Distribution Channel
  • Figure 50: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 51: Latin America Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 52: Latin America Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 53: Latin America Market Attractiveness Analysis by Product
  • Figure 54: Latin America Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 55: Latin America Market Y-o-Y Growth Comparison by Application, 2026 to 2036
  • Figure 56: Latin America Market Attractiveness Analysis by Application
  • Figure 57: Latin America Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 58: Latin America Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 59: Latin America Market Attractiveness Analysis by End Use
  • Figure 60: Latin America Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 61: Latin America Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 62: Latin America Market Attractiveness Analysis by Technology
  • Figure 63: Latin America Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 64: Latin America Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 65: Latin America Market Attractiveness Analysis by Sample Type
  • Figure 66: Latin America Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
  • Figure 67: Latin America Market Y-o-Y Growth Comparison by Distribution Channel, 2026 to 2036
  • Figure 68: Latin America Market Attractiveness Analysis by Distribution Channel
  • Figure 69: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 70: Western Europe Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 71: Western Europe Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 72: Western Europe Market Attractiveness Analysis by Product
  • Figure 73: Western Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 74: Western Europe Market Y-o-Y Growth Comparison by Application, 2026 to 2036
  • Figure 75: Western Europe Market Attractiveness Analysis by Application
  • Figure 76: Western Europe Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 77: Western Europe Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 78: Western Europe Market Attractiveness Analysis by End Use
  • Figure 79: Western Europe Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 80: Western Europe Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 81: Western Europe Market Attractiveness Analysis by Technology
  • Figure 82: Western Europe Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 83: Western Europe Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 84: Western Europe Market Attractiveness Analysis by Sample Type
  • Figure 85: Western Europe Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
  • Figure 86: Western Europe Market Y-o-Y Growth Comparison by Distribution Channel, 2026 to 2036
  • Figure 87: Western Europe Market Attractiveness Analysis by Distribution Channel
  • Figure 88: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 89: Eastern Europe Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 90: Eastern Europe Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 91: Eastern Europe Market Attractiveness Analysis by Product
  • Figure 92: Eastern Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 93: Eastern Europe Market Y-o-Y Growth Comparison by Application, 2026 to 2036
  • Figure 94: Eastern Europe Market Attractiveness Analysis by Application
  • Figure 95: Eastern Europe Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 96: Eastern Europe Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 97: Eastern Europe Market Attractiveness Analysis by End Use
  • Figure 98: Eastern Europe Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 99: Eastern Europe Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 100: Eastern Europe Market Attractiveness Analysis by Technology
  • Figure 101: Eastern Europe Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 102: Eastern Europe Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 103: Eastern Europe Market Attractiveness Analysis by Sample Type
  • Figure 104: Eastern Europe Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
  • Figure 105: Eastern Europe Market Y-o-Y Growth Comparison by Distribution Channel, 2026 to 2036
  • Figure 106: Eastern Europe Market Attractiveness Analysis by Distribution Channel
  • Figure 107: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 108: East Asia Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 109: East Asia Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 110: East Asia Market Attractiveness Analysis by Product
  • Figure 111: East Asia Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 112: East Asia Market Y-o-Y Growth Comparison by Application, 2026 to 2036
  • Figure 113: East Asia Market Attractiveness Analysis by Application
  • Figure 114: East Asia Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 115: East Asia Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 116: East Asia Market Attractiveness Analysis by End Use
  • Figure 117: East Asia Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 118: East Asia Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 119: East Asia Market Attractiveness Analysis by Technology
  • Figure 120: East Asia Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 121: East Asia Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 122: East Asia Market Attractiveness Analysis by Sample Type
  • Figure 123: East Asia Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
  • Figure 124: East Asia Market Y-o-Y Growth Comparison by Distribution Channel, 2026 to 2036
  • Figure 125: East Asia Market Attractiveness Analysis by Distribution Channel
  • Figure 126: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 127: South Asia and Pacific Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 128: South Asia and Pacific Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 129: South Asia and Pacific Market Attractiveness Analysis by Product
  • Figure 130: South Asia and Pacific Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 131: South Asia and Pacific Market Y-o-Y Growth Comparison by Application, 2026 to 2036
  • Figure 132: South Asia and Pacific Market Attractiveness Analysis by Application
  • Figure 133: South Asia and Pacific Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 134: South Asia and Pacific Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 135: South Asia and Pacific Market Attractiveness Analysis by End Use
  • Figure 136: South Asia and Pacific Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 137: South Asia and Pacific Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 138: South Asia and Pacific Market Attractiveness Analysis by Technology
  • Figure 139: South Asia and Pacific Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 140: South Asia and Pacific Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 141: South Asia and Pacific Market Attractiveness Analysis by Sample Type
  • Figure 142: South Asia and Pacific Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
  • Figure 143: South Asia and Pacific Market Y-o-Y Growth Comparison by Distribution Channel, 2026 to 2036
  • Figure 144: South Asia and Pacific Market Attractiveness Analysis by Distribution Channel
  • Figure 145: Middle East & Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 146: Middle East & Africa Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 147: Middle East & Africa Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 148: Middle East & Africa Market Attractiveness Analysis by Product
  • Figure 149: Middle East & Africa Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 150: Middle East & Africa Market Y-o-Y Growth Comparison by Application, 2026 to 2036
  • Figure 151: Middle East & Africa Market Attractiveness Analysis by Application
  • Figure 152: Middle East & Africa Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 153: Middle East & Africa Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 154: Middle East & Africa Market Attractiveness Analysis by End Use
  • Figure 155: Middle East & Africa Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 156: Middle East & Africa Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 157: Middle East & Africa Market Attractiveness Analysis by Technology
  • Figure 158: Middle East & Africa Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 159: Middle East & Africa Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 160: Middle East & Africa Market Attractiveness Analysis by Sample Type
  • Figure 161: Middle East & Africa Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
  • Figure 162: Middle East & Africa Market Y-o-Y Growth Comparison by Distribution Channel, 2026 to 2036
  • Figure 163: Middle East & Africa Market Attractiveness Analysis by Distribution Channel
  • Figure 164: Global Market - Tier Structure Analysis
  • Figure 165: Global Market - Company Share Analysis
Related Reports

Related Reports

Blood Collection Tube for Liquid Biopsy Market

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services